Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.43 |
| ▸ | PRKDC | P78527 | 6/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 3/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13953623 | 0.85 | ALOX5 (0.39) | ALOX5PRKDCPIK3CDPIK3CBATM | |
| SCHEMBL13228979 | 0.85 | MAOA (0.36) | ATMMAOAMAOBMAPT | |
| SCHEMBL13228985 | 0.85 | MAOA (0.36) | ATMMAOAMAOBMAPT | |
| SCHEMBL9920849 | 0.83 | ALOX5 (0.45) | ALOX5PRKDCPIK3CDPIK3CBMAOA | |
| SCHEMBL13872456 | 0.83 | ALOX5 (0.45) | ALOX5PRKDCPIK3CDPIK3CBMAOA | |
| SCHEMBL9920785 | 0.82 | ALOX5 (0.49) | ALOX5PRKDCPIK3CDPIK3CBATM | |
| SCHEMBL13228980 | 0.82 | ALDH1A1 (0.31) | KDM4E | |
| SCHEMBL9920852 | 0.81 | ALOX5 (0.48) | ALOX5PRKDCPIK3CDPIK3CBATM | |
| SCHEMBL9920847 | 0.81 | ALOX5 (0.48) | ALOX5PRKDCPIK3CDPIK3CBATM | |
| SCHEMBL9920770 | 0.81 | ALOX5 (0.48) | ALOX5PRKDCPIK3CDPIK3CBATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8729530-B2 | Material for light-emitting device and light-emitting device | TORAY INDUSTRIES, INC. (JP) | 2014-05-20 | — | — | US | disclosed |
| US-8729530-B2 | Material for light-emitting device and light-emitting device | TORAY INDUSTRIES, INC. (JP) | 2014-05-20 | — | — | US | disclosed |
| US-20100163852-A1 | Material for light-emitting device and light-emitting device | TORAY INDUSTRIES, INC. (JP) | 2010-07-01 | — | — | US | disclosed |
| US-20100163852-A1 | Material for light-emitting device and light-emitting device | TORAY INDUSTRIES, INC. (JP) | 2010-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100163852-A1 | Material for light-emitting device and light-emitting device | CRY1, CRY2, S100A10 | ALOX5 1466/4885PRKDC 4636/4885PIK3CD 4798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.